WALT SARGEANT: Open Payments
NPI 1720081433 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,776 in 107 payments from 19 companies in 2025. Trend: 2023 $2,600 · 2024 $2,704 · 2025 $2,776
Food & beverage: $2,602Education: $174
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $397 |
| ViiV Healthcare Company | 15 | $376 |
| Gilead Sciences, Inc. | 9 | $307 |
| Astellas Pharma US Inc | 5 | $277 |
| Novo Nordisk Inc | 9 | $248 |
| Lilly USA, LLC | 10 | $175 |
| GlaxoSmithKline, LLC. | 7 | $164 |
| Exact Sciences Corporation | 7 | $160 |
| Abbott Laboratories | 8 | $160 |
| Phathom Pharmaceuticals, Inc. | 5 | $118 |
Products named: APRETUDE, BREZTRI, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, MOUNJARO, Descovy, VOQUEZNA, FARXIGA.
Industry payments across NY — which companies pay providers there.
